about
Practical application of the neuroregenerative properties of ketamine: real world treatment experience'Special k' and a loss of cell-to-cell adhesion in proximal tubule-derived epithelial cells: modulation of the adherens junction complex by ketamineRepeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats.Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine.Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine."Word of mouse": indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine.Effects of long-term ketamine administration on rat bladder protein levels: a proteomic investigation using two-dimensional difference gel electrophoresis system.Ketamine/Xylazine-Induced Corneal Damage in Mice.Ketamine bladder syndrome: an important differential diagnosis when assessing a patient with persistent lower urinary tract symptoms.Acute and chronic toxicity pattern in ketamine abusers in Hong KongKetamine-Induced Apoptosis in Normal Human Urothelial Cells: A Direct, N-Methyl-d-Aspartate Receptor-Independent Pathway Characterized by Mitochondrial Stress.Chronic biliary colic associated with ketamine abuse.Evaluation of the extent of ketamine-induced uropathy: the role of CT urography.'Legal highs'--novel and emerging psychoactive drugs: a chemical overview for the toxicologist.From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine.Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity.Nerve hyperplasia: a unique feature of ketamine cystitis.Bilateral hydronephrosis and cystitis resulting from chronic ketamine abuse.Demonstration of the direct impact of ketamine on urothelium using a tissue engineered bladder model.Ketamine and damage to the urinary tract.One-stop clinic for ketamine-associated uropathy: report on service delivery model, patients' characteristics and non-invasive investigations at baseline by a cross-sectional study in a prospective cohort of 318 teenagers and young adults.Treatment of ketamine-associated cystitis with chondroitin sulphate.The Immunomodulatory Imbalance in Patients with Ketamine Cystitis.Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1.The effects of recreational ketamine cystitis on urinary tract reconstruction - a surgical challenge.The fibrosis of ketamine, a noncompetitive N-methyl-d-aspartic acid receptor antagonist dose-dependent change in a ketamine-induced cystitis rat model.Clinical pattern and prevalence of upper gastrointestinal toxicity in patients abusing ketamine.Where next in ketamine uropathy? Dedicated management centres?Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier.Ketamine cystitis: practical considerations in management.Replacing immunoassays for mephedrone, ketamines and six amphetamine-type stimulants with flow injection analysis tandem mass spectrometry.Ketamine uropathy: rising to the challenges of a new condition.Sexual dysfunction in women with ketamine cystitis: a case-control study.
P2860
Q26748766-80EBBF17-5731-4F24-9D74-2EDB11428015Q28535969-DE701418-A75B-46D4-BA5A-313F644D868CQ30547324-9A8DD031-8462-4B22-80D6-D2DA5A373A68Q34030028-90590316-7CF1-409B-B5C8-93422042AE97Q34258539-5B4FF35D-62BD-43B8-AD44-CD2BA0DD4499Q34464501-7596AEE5-D4B0-4E89-9B4D-8DA2B4D45168Q34573628-DDBD0EF4-FC0C-4457-9D7F-C8267C3DF2D8Q35723733-411568B2-DFB4-4ABE-8A13-893E327ADFD4Q35980445-198955C5-D7E0-4D75-A89F-F947C9344B98Q36548788-A14E6EBB-A299-417A-A5E4-6D283B3435FFQ36885697-D1E28B54-F695-4439-98B0-9ED0AD8C68B8Q36982218-3EB8DC99-BAE9-410B-AB09-367ED6448BB8Q37658695-38DEDBE9-9465-4283-A0B5-0B7FF4838680Q37976107-153BF46D-159A-4794-B66B-CB53AE8B56DBQ38082838-35098349-DC7E-4879-A494-DA25956E6DE8Q39246120-3CD4294A-F91A-4E73-A0D0-A6E834359B11Q41874803-B32FD3C6-8FF2-4D20-86CB-BC612BFC006BQ42023427-8BC89947-D140-44AF-AB68-16183803F3AAQ42077939-6D68E130-24B2-45D2-8A24-EAC2E1637B0DQ43705895-2960C26B-E7F4-4207-9521-F5B6F0A48960Q43974460-DD8D3742-6AFA-4124-A34F-89C06E3217AFQ44375500-7C28AC4E-FCF7-45C6-B214-E1229B7EF7E6Q47160503-BC0EF345-C70C-4645-87A8-B0237A4C9C30Q47316195-DAF5BBBF-AB82-42BB-8262-AB74E54230D6Q47325469-652751CE-86A4-4C1A-8326-48CBA1E3B727Q47657800-E86892B7-B186-42D0-8C87-5154AB680C20Q47685055-2AF97125-1924-4FC9-9A8E-A8CAFB5F824EQ47796952-825296D2-5D78-42E9-A792-AFB1ED652329Q47834045-6D7FA328-5261-4941-9E3E-FCF9AF5DE052Q47877869-19E510DA-ABAD-4145-8B67-0A94058A5063Q48134965-AA8F4092-9265-465D-A903-D74FBA842464Q48181356-501D532D-7B9F-4707-B019-80D4409C3E90Q48202808-7386D343-0143-4A0E-8D6A-939E9A14F23A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recreational ketamine: from pleasure to pain.
@en
Recreational ketamine: from pleasure to pain.
@nl
type
label
Recreational ketamine: from pleasure to pain.
@en
Recreational ketamine: from pleasure to pain.
@nl
prefLabel
Recreational ketamine: from pleasure to pain.
@en
Recreational ketamine: from pleasure to pain.
@nl
P2093
P2860
P1433
P1476
Recreational ketamine: from pleasure to pain.
@en
P2093
Angela Cottrell
Christopher Woodhouse
David Gillatt
Maya Harris
Simon Fulford
P2860
P304
P356
10.1111/J.1464-410X.2010.10031.X
P577
2011-02-14T00:00:00Z